Back
Dave Vs. Akero Therapeutics Industry Stock Comparison
Buy
90
DAVE
Dave
Last Price:
$274.23
Seasonality Move:
-4.85%
Buy
60
AKRO
Akero Therapeutics
Last Price:
$54.65
Seasonality Move:
34.97%
Buy
60
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $56.19. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVE Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $56.19The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.72 | Buy |
Relative Strength Index (14 RSI): | 69.64 | Buy |
Chaikin Money Flow: | 180113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (202.75 - 230.19) | Buy |
Bollinger Bands (100): | (76.33 - 188.57) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.45 | Buy |
Relative Strength Index (14 RSI): | 67.53 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.33 - 55.87) | Buy |
Bollinger Bands (100): | (40.08 - 52.38) | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 222.38 | Buy |
20-day SMA: | 219.06 | Buy |
50-day SMA: | 172.27 | Buy |
200-day SMA: | 99.96 | Buy |
8-day EMA: | 229.72 | Buy |
20-day EMA: | 216.55 | Buy |
50-day EMA: | 182.76 | Buy |
200-day EMA: | 113.67 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55 | Buy |
20-day SMA: | 54.01 | Buy |
50-day SMA: | 47.06 | Buy |
200-day SMA: | 38.07 | Buy |
8-day EMA: | 55.12 | Buy |
20-day EMA: | 53.19 | Buy |
50-day EMA: | 48.99 | Buy |
200-day EMA: | 39.98 | Buy |
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.35 per share, an increase next quarter of $0.53 per share, an increase this year of $4.51 per share, and an increase next year of $1.19 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Dave Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |